GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)
Hong Kong
· Delayed Price · Currency is HKD
41.30
-1.48 (-3.46%)
Last updated: Apr 29, 2026, 1:38 PM HKT
HKG:2595 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 130.27 | 104.7 | 73.73 |
| Revenue Growth (YoY) | 24.42% | 42.00% | - |
| Cost of Revenue | 46.61 | 20.1 | 0.68 |
| Gross Profit | 83.66 | 84.61 | 73.05 |
| Selling, General & Admin | 81.38 | 58.08 | 49.95 |
| Research & Development | 282.26 | 332.12 | 308.94 |
| Operating Expenses | 363.64 | 390.21 | 358.88 |
| Operating Income | -279.98 | -305.6 | -285.83 |
| Interest Expense | -6.39 | -6.12 | -1.49 |
| Interest & Investment Income | 31.18 | 17.23 | 10.77 |
| Currency Exchange Gain (Loss) | -23.84 | 3.54 | 3.82 |
| Other Non Operating Income (Expenses) | 3.32 | -4.97 | 21.75 |
| EBT Excluding Unusual Items | -275.71 | -295.92 | -250.98 |
| Gain (Loss) on Sale of Investments | 0.19 | 0.4 | 3.59 |
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0.14 |
| Other Unusual Items | -1,519 | -382.11 | -260.79 |
| Pretax Income | -1,794 | -677.64 | -508.32 |
| Income Tax Expense | 0.15 | - | - |
| Net Income | -1,795 | -677.64 | -508.32 |
| Net Income to Common | -1,795 | -677.64 | -508.32 |
| Shares Outstanding (Basic) | 296 | 259 | 220 |
| Shares Outstanding (Diluted) | 296 | 259 | 220 |
| Shares Change (YoY) | 14.39% | 17.40% | - |
| EPS (Basic) | -6.07 | -2.62 | -2.31 |
| EPS (Diluted) | -6.07 | -2.62 | -2.31 |
| Free Cash Flow | -135.81 | -206.64 | -202.65 |
| Free Cash Flow Per Share | -0.46 | -0.80 | -0.92 |
| Gross Margin | 64.22% | 80.81% | 99.07% |
| Operating Margin | -214.93% | -291.87% | -387.66% |
| Profit Margin | -1377.58% | -647.20% | -689.40% |
| Free Cash Flow Margin | -104.25% | -197.35% | -274.85% |
| EBITDA | -274.53 | -297.1 | -274.33 |
| EBITDA Margin | -210.74% | -283.76% | - |
| D&A For EBITDA | 5.46 | 8.5 | 11.5 |
| EBIT | -279.98 | -305.6 | -285.83 |
| EBIT Margin | -214.93% | -291.87% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.